Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2006 5
2007 4
2008 7
2009 3
2010 6
2011 6
2012 5
2013 10
2014 7
2015 6
2016 9
2017 7
2018 11
2019 14
2020 17
2021 10
2022 7
2023 12
2024 14
2025 9
2026 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma.
Yang W, Xing X, Yeung SJ, Wang S, Chen W, Bao Y, Wang F, Feng S, Peng F, Wang X, Chen S, He M, Zhang N, Wang H, Zeng B, Liu Z, Kidane B, Seder CW, Koyanagi K, Shargall Y, Luo H, Peng S, Cheng C. Yang W, et al. Among authors: bao y. J Immunother Cancer. 2022 Jan;10(1):e003497. doi: 10.1136/jitc-2021-003497. J Immunother Cancer. 2022. PMID: 35022193 Free PMC article.
Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002).
Chen B, Liu S, Zhu Y, Zhang J, Bao Y, Meng F, Zhang L, Cheng X, Xuzhang W, Chen B, Wang R, Li Z, Hu Y, Liu M, Lv Y, Li J, Dragomir MP, Chen M, Li Q, Yang H, Xi M. Chen B, et al. Among authors: bao y. J Clin Oncol. 2026 Jun;44(16):1508-1519. doi: 10.1200/JCO-25-03044. Epub 2026 Apr 10. J Clin Oncol. 2026. PMID: 41962116 Clinical Trial.
Induction chemotherapy plus camrelizumab followed by concurrent chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma: a single-arm phase II trial.
Peng F, Wu J, Lian H, Wu S, Niu S, Xing X, Yang W, Song W, Li Y, Yu H, Feng ST, Wang X, Chen W, Ye W, Yu T, Liufu W, Cheng C, Bao Y. Peng F, et al. Among authors: bao y. Nat Commun. 2025 Nov 21;16(1):10292. doi: 10.1038/s41467-025-65206-z. Nat Commun. 2025. PMID: 41271680 Free PMC article. Clinical Trial.
Long-Term Outcomes of Concurrent Chemoradiotherapy With S-1 in Older Patients With Esophageal Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Ji Y, Fang M, Zhu W, Yang Y, Ma J, Zhang L, Li J, Tao H, Xia J, Yang H, Huang J, Bao Y, Du D, Liu D, Wang X, Li C, Yang X, Zeng M, Liu Z, Zheng W, Pu J, Chen J, Hu W, Wang X, Li P, Wang J, Xu Y, Zheng X, Chen K, Wang W, Tao G, Cai J, Zhao J, Zhu J, Jiang M, Yan Y, Xu G, Xu W, Bu S, Song B, Xie K, Huang S, Zheng Y, Sheng L, Lai X, Chen Y, Cheng L, Hu X, Ji W, Kong Y, Yu X, Li H, Li R, Huang R, He H, Du X, Chen M. Ji Y, et al. Among authors: bao y. JAMA Netw Open. 2026 Mar 2;9(3):e263541. doi: 10.1001/jamanetworkopen.2026.3541. JAMA Netw Open. 2026. PMID: 41893843 Free PMC article. Clinical Trial.
Long-term outcomes and exploratory analysis from a randomized phase 3 trial of radiation dose escalation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
Cheng Q, Dong B, Zhu W, Li J, Huang R, Lin X, Sun Z, Yang X, Liu L, He H, Su Y, Wang C, Kong Y, Wang W, He H, Zeng M, Pu J, Hu W, Bao Y, Liu Z, Ma J, Jiang H, Guo H, Xu Y, Chen M. Cheng Q, et al. Among authors: bao y. Drug Resist Updat. 2026 Sep;88:101446. doi: 10.1016/j.drup.2026.101446. Epub 2026 Jul 9. Drug Resist Updat. 2026. PMID: 42442129 Clinical Trial.
163 results